Drug recall · November 12, 2014
PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN recall
Why: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN, 27.7mg/0.45mg/45.45mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
- Lots / codes
Lot #: 20140912@25, discard date: 10/27/2014
- Quantity
- 5 mL
- Company
- Oregon Compounding Centers, Inc. dba Creative Compounds, Wilsonville, OR
- Distribution
- Oregon, Washington
- Initiated
- October 6, 2014 · Voluntary: Firm initiated
- Classified
- October 31, 2014
- Reported
- November 12, 2014
- Ended
- June 30, 2015
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Papaverine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.